|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 267.20 USD | +0.34% |
|
-2.38% | +4.16% |
| Capitalization | 32.03B 27.26B 25.32B 23.74B 44.2B 2,933B 46.86B 289B 115B 1,386B 120B 118B 5,071B | P/E ratio 2025 * |
21.3x | P/E ratio 2026 * | 22.9x |
|---|---|---|---|---|---|
| Enterprise value | 39.82B 33.89B 31.48B 29.51B 54.95B 3,647B 58.26B 359B 142B 1,723B 149B 146B 6,305B | EV / Sales 2025 * |
0.31x | EV / Sales 2026 * | 0.27x |
| Free-Float |
60.46% | Yield 2025 * |
1.37% | Yield 2026 * | 1.49% |
Last Transcript: Humana Inc.
| 1 day | +0.34% | ||
| 1 week | -2.38% | ||
| Current month | +4.16% | ||
| 1 month | +3.76% | ||
| 3 months | -8.42% | ||
| 6 months | +12.51% | ||
| Current year | +4.16% |
| 1 week | 264.04 |  | 279.58 |
| 1 month | 254.38 | | 285.6 |
| Current year | 256.04 | | 285.6 |
| 1 year | 206.87 | | 315.35 |
| 3 years | 206.87 | | 541.21 |
| 5 years | 206.87 | | 571.3 |
| 10 years | 150 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 11/01/2025 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 01/01/2014 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 01/09/2003 |
Karen Katz
BRD | Director/Board Member | 69 | 23/09/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 2.3% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.34% | -2.38% | -9.20% | -46.06% | 32.03B | |
| +0.15% | +7.35% | -32.92% | -26.85% | 321B | |
| -0.51% | -1.09% | -7.62% | -22.42% | 82.73B | |
| -0.56% | +2.49% | -5.43% | -9.47% | 74.9B | |
| +0.57% | -0.22% | -29.90% | -39.77% | 22.32B | |
| +0.08% | +3.95% | -35.06% | -33.07% | 10.22B | |
| -0.15% | +4.87% | +61.94% | +92.30% | 4.72B | |
| +0.46% | +2.37% | +13.99% | -25.14% | 2.16B | |
| Average | +0.05% | +0.39% | -5.52% | -13.81% | 68.77B | |
| Weighted average by Cap. | -0.02% | +1.99% | -22.91% | -24.55% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 129B 110B 102B 95.77B 178B 11,836B 189B 1,166B 462B 5,591B 485B 475B 20,460B | 145B 124B 115B 108B 201B 13,313B 213B 1,312B 520B 6,289B 545B 534B 23,012B |
| Net income | 1.51B 1.28B 1.19B 1.12B 2.08B 138B 2.21B 13.62B 5.4B 65.28B 5.66B 5.54B 239B | 1.42B 1.21B 1.12B 1.05B 1.96B 130B 2.08B 12.81B 5.08B 61.42B 5.32B 5.21B 225B |
| Net Debt | 7.79B 6.63B 6.16B 5.77B 10.75B 714B 11.4B 70.32B 27.87B 337B 29.22B 28.62B 1,234B | 7.78B 6.62B 6.15B 5.77B 10.74B 713B 11.39B 70.23B 27.83B 337B 29.18B 28.58B 1,232B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 266.40 $ | +0.04% | 189,173 |
| 22/01/26 | 266.29 $ | -1.62% | 1,096,065 |
| 21/01/26 | 270.67 $ | +1.00% | 1,255,490 |
| 20/01/26 | 268.00 $ | -1.93% | 1,537,272 |
| 16/01/26 | 273.28 $ | -3.76% | 885,654 |
Delayed Quote Nyse, January 23, 2026 at 08:37 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition